Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Radiotherapy × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 12 Prostatic Neoplasms 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 7 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Radiation Injuries 3 Esophageal Neoplasms 3 Carcinoma 3 Vaginal Neoplasms 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Follicular 2 Liposarcoma 2

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡